...
search icon
mgx-img

Metagenomi, Inc. Common Stock, Common Stock

MGX

NSQ

$2.61

+$0.16

(6.53%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$97.68M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
974.99K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.61 L
$12.5 H
$2.61

About Metagenomi, Inc. Common Stock, Common Stock

Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. It has a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited T-cell receptor-based therapeutic products in the field of treatment, prevention, or diagnosis of human cancer; and a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop, and commercialize investigational medicines using genome editing technologies. The company was incorporated in 2016 and is based in Emeryville, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameMGXSectorS&P500
1-Week Return5.24%-0.03%1.53%
1-Month Return-5.43%4.56%4.75%
3-Month Return38.83%1.29%2.77%
6-Month Return-15.81%-3.54%12.18%
1-Year Return-78.69%1.59%22.34%
3-Year Return-82.6%13.55%38.91%

Financials

Sep '21Sep '22Sep '23
Total Revenue243.00K17.20M44.76M[{"date":"2021-09-30","value":0.54,"profit":true},{"date":"2022-09-30","value":38.43,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Cost of Revenue387.00K1.73M94.40M[{"date":"2021-09-30","value":0.41,"profit":true},{"date":"2022-09-30","value":1.84,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Gross Profit(144.00K)15.47M(49.65M)[{"date":"2021-09-30","value":-0.93,"profit":false},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":-320.99,"profit":false}]
Gross Margin(59.26%)89.92%(110.93%)[{"date":"2021-09-30","value":-65.9,"profit":false},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":-123.36,"profit":false}]
Operating Expenses24.19M61.84M123.25M[{"date":"2021-09-30","value":19.63,"profit":true},{"date":"2022-09-30","value":50.18,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Operating Income(23.95M)(44.64M)(78.49M)[{"date":"2021-09-30","value":-2394700000,"profit":false},{"date":"2022-09-30","value":-4464000000,"profit":false},{"date":"2023-09-30","value":-7849200000,"profit":false}]
Total Non-Operating Income/Expense2.25M6.94M33.73M[{"date":"2021-09-30","value":6.66,"profit":true},{"date":"2022-09-30","value":20.57,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Pre-Tax Income(21.44M)(41.02M)(60.23M)[{"date":"2021-09-30","value":-2144200000,"profit":false},{"date":"2022-09-30","value":-4102400000,"profit":false},{"date":"2023-09-30","value":-6022800000,"profit":false}]
Income Taxes306.00K2.57M8.03M[{"date":"2021-09-30","value":3.81,"profit":true},{"date":"2022-09-30","value":32,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Income After Taxes(21.75M)(43.59M)(68.25M)[{"date":"2021-09-30","value":-2174800000,"profit":false},{"date":"2022-09-30","value":-4359300000,"profit":false},{"date":"2023-09-30","value":-6825500000,"profit":false}]
Income From Continuous Operations(21.44M)(43.59M)(68.25M)[{"date":"2021-09-30","value":-2144200000,"profit":false},{"date":"2022-09-30","value":-4359300000,"profit":false},{"date":"2023-09-30","value":-6825500000,"profit":false}]
Income From Discontinued Operations---[{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Net Income(21.44M)(43.59M)(68.25M)[{"date":"2021-09-30","value":-2144200000,"profit":false},{"date":"2022-09-30","value":-4359300000,"profit":false},{"date":"2023-09-30","value":-6825500000,"profit":false}]
EPS (Diluted)---[{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MGX
Cash Ratio 6.01
Current Ratio 6.18

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MGX
ROA (LTM) -14.85%
ROE (LTM) -30.34%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MGX
Debt Ratio Lower is generally better. Negative is bad. 0.29
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.71

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MGX
Trailing PE NM
Forward PE NM
P/S (TTM) 1.77
P/B 0.38
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Metagenomi, Inc. Common Stock share price today?

Metagenomi, Inc. Common Stock (MGX) share price today is $2.61

Can Indians buy Metagenomi, Inc. Common Stock shares?

Yes, Indians can buy shares of Metagenomi, Inc. Common Stock (MGX) on Vested. To buy Metagenomi, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MGX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Metagenomi, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Metagenomi, Inc. Common Stock (MGX) via the Vested app. You can start investing in Metagenomi, Inc. Common Stock (MGX) with a minimum investment of $1.

How to invest in Metagenomi, Inc. Common Stock shares from India?

You can invest in shares of Metagenomi, Inc. Common Stock (MGX) via Vested in three simple steps:

  • Click on Sign Up or Invest in MGX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Metagenomi, Inc. Common Stock shares
What is Metagenomi, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Metagenomi, Inc. Common Stock (MGX) is $12.5. The 52-week low price of Metagenomi, Inc. Common Stock (MGX) is $1.61.

What is Metagenomi, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Metagenomi, Inc. Common Stock (MGX) is 0.38

What is the Market Cap of Metagenomi, Inc. Common Stock?

The market capitalization of Metagenomi, Inc. Common Stock (MGX) is $97.68M

What is Metagenomi, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Metagenomi, Inc. Common Stock is MGX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top